» Articles » PMID: 22176890

Interaction Between Pathogenic Proteins in Neurodegenerative Disorders

Overview
Journal J Cell Mol Med
Date 2011 Dec 20
PMID 22176890
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The misfolding and progressive aggregation of specific proteins in selective regions of the nervous system is a seminal occurrence in many neurodegenerative disorders, and the interaction between pathological/toxic proteins to cause neurodegeneration is a hot topic of current neuroscience research. Despite clinical, genetic and experimental differences, increasing evidence indicates considerable overlap between synucleinopathies, tauopathies and other protein-misfolding diseases. Inclusions, often characteristic hallmarks of these disorders, suggest interactions of pathological proteins enganging common downstream pathways. Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Alzheimer, Parkinson, Huntington and prion diseases, have confirmed correlations/overlaps between these and other neurodegenerative disorders. Emerging evidence, in addition to synergistic effects of tau protein, amyloid-β, α-synuclein and other pathologic proteins, suggests that prion-like induction and spreading, involving secreted proteins, are major pathogenic mechanisms in various neurodegenerative diseases, depending on genetic backgrounds and environmental factors. The elucidation of the basic molecular mechanisms underlying the interaction and spreading of pathogenic proteins, suggesting a dualism or triad of neurodegeneration in protein-misfolding disorders, is a major challenge for modern neuroscience, to provide a deeper insight into their pathogenesis as a basis of effective diagnosis and treatment.

Citing Articles

Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET.

Mak E, Przybelski S, Wiste H, Fought A, Schwarz C, Senjem M Alzheimers Dement. 2025; 21(2):e14571.

PMID: 39935389 PMC: 11815207. DOI: 10.1002/alz.14571.


Cerebrospinal fluid α-synuclein adds the risk of cognitive decline and is associated with tau pathology among non-demented older adults.

Liu W, Li W, Liu Z, Wang X, Guo M, Wang S Alzheimers Res Ther. 2024; 16(1):103.

PMID: 38725083 PMC: 11084056. DOI: 10.1186/s13195-024-01463-2.


Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight.

Vogel J, Corriveau-Lecavalier N, Franzmeier N, Pereira J, Brown J, Maass A Nat Rev Neurosci. 2023; 24(10):620-639.

PMID: 37620599 DOI: 10.1038/s41583-023-00731-8.


Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.

Jellinger K J Neural Transm (Vienna). 2023; 130(12):1491-1508.

PMID: 37418039 DOI: 10.1007/s00702-023-02670-1.


Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.

Jellinger K J Neural Transm (Vienna). 2023; 130(7):891-904.

PMID: 37306790 DOI: 10.1007/s00702-023-02660-3.


References
1.
Braak H, Del Tredici K . Alzheimer's pathogenesis: is there neuron-to-neuron propagation?. Acta Neuropathol. 2011; 121(5):589-95. DOI: 10.1007/s00401-011-0825-z. View

2.
Frasier M, WALZER M, McCarthy L, Magnuson D, Lee J, Haas C . Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp Neurol. 2005; 192(2):274-87. DOI: 10.1016/j.expneurol.2004.07.016. View

3.
Coomaraswamy J, Kilger E, Wolfing H, Schafer C, Kaeser S, Wegenast-Braun B . Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A. 2010; 107(17):7969-74. PMC: 2867864. DOI: 10.1073/pnas.1001056107. View

4.
Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M . beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A. 2001; 98(21):12245-50. PMC: 59799. DOI: 10.1073/pnas.211412398. View

5.
Hu W, Chen-Plotkin A, Arnold S, Grossman M, Clark C, Shaw L . Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol. 2010; 120(3):385-99. PMC: 2982700. DOI: 10.1007/s00401-010-0723-9. View